Skip to main content

Research Repository

Advanced Search

The patientsʼ perspective of important glucocorticoid effects: A nominal group study among patients with Systemic Lupus Erythematosus and Myositis

Mirza, Serene Z.; Cheah, Jonathan T. L.; Ghosh, Nilasha; Robson, Joanna C.; Hill, Catherine L.; Singh, Jasvinder; Mackie, Sarah L.; Navarro-Millán, Iris; Simon, Lee S.; Goodman, Susan M.

Authors

Serene Z. Mirza

Jonathan T. L. Cheah

Nilasha Ghosh

Jo Robson Jo.Robson@uwe.ac.uk
Consultant Associate Professor in Rheumatology

Catherine L. Hill

Jasvinder Singh

Sarah L. Mackie

Iris Navarro-Millán

Lee S. Simon

Susan M. Goodman



Abstract

Background/Objective The objective of this cohort study was to understand the positive and negative effects of glucocorticoids (GCs) in patients with systemic lupus erythematosus and myositis from the patients' perspective with the aim of developing a patient-reported outcome measure. Methods Included patients were asked to participate in 1 of 5 nominal groups where demographic information and a quality-of-life questionnaire were collected. Patients were asked 2 open-ended questions on (1) benefits and (2) harms related to GC use. We used the Nominal Group Technique, a highly structured consensus method in which responses are generated, shared, and ranked. Descriptive statistics were used to summarize the results. Nominal group sessions took place from April to May 2019. Results Of 206 patients who were approached, 21 patients participated, 17 with systemic lupus erythematosus and 4 with myositis, predominantly women with more than 10 years of steroid use. The domains ranked highest for GC benefits were disease control (55 votes), fast onset of action (30 votes), increased energy (10 votes), and pain relief (10 votes). The highest-ranked negative effects were bone loss (38 votes) and weight gain (16 votes); psychological effects and damaged internal organs each received 12 votes. Conclusions The top-ranked GC effects - both benefits and harms - among patients with systemic rheumatic disease are consistent with the top domains associated with GC use reported with other inflammatory diseases. This study informs the development of a comprehensive patient-reported outcome measure that can be used across inflammatory diseases.

Journal Article Type Article
Acceptance Date Nov 4, 2019
Online Publication Date Jan 24, 2020
Publication Date 2021-09
Deposit Date May 15, 2020
Publicly Available Date Jan 25, 2021
Journal Journal of Clinical Rheumatology
Print ISSN 1076-1608
Electronic ISSN 1536-7355
Publisher Lippincott, Williams & Wilkins
Peer Reviewed Peer Reviewed
Volume 27
Issue 6
Pages 232-238
DOI https://doi.org/10.1097/RHU.0000000000001313
Keywords Rheumatology, glucocorticoids, myositis, nominal group, patient perspective, systemic lupus erythematosus
Public URL https://uwe-repository.worktribe.com/output/5975299
Publisher URL https://journals.lww.com/jclinrheum/Abstract/9000/The_Patients__Perspective_of_Important.98780.aspx

Files

The patients’ perspective of important glucocorticoid effects: A nominal group study amongst patients with systemic lupus erythematosus and myositis (907 Kb)
PDF

Licence
http://creativecommons.org/licenses/by-nc/4.0/

Publisher Licence URL
http://creativecommons.org/licenses/by-nc/4.0/

Copyright Statement
This is the accepted manuscript of an article accepted for publication in JCR: Journal of Clinical Rheumatology. The final version is available here: https://journals.lww.com/jclinrheum/Abstract/9000/The_Patients__Perspective_of_Important.98780.aspx





You might also like



Downloadable Citations